E. Gomez

发表

[Assessment of endothelial function in autoimmune diseases].

V. Richard, H. Lévesque, R. Joannidés, 2014, La Revue de medecine interne.

Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.

P. Mulder, V. Richard, M. Tremblay, 2012, Journal of molecular and cellular cardiology.

Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension

V. Richard, F. Bounoure, M. Skiba, 2011, Journal of hypertension.

Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure

P. Mulder, V. Richard, J. Martinet, 2016, Circulation. Heart failure.

Role of protein tyrosine phosphatase 1B in cardiovascular diseases.

V. Richard, M. Besnier, Pierre-Alain Thiébaut, 2016, Journal of molecular and cellular cardiology.

Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension

V. Richard, F. Bounoure, M. Skiba, 2010, Journal of hypertension.

Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats.

M. Félétou, T. Verbeuren, J. Paysant, 2008, American journal of physiology. Heart and circulatory physiology.

Gene Deletion of Protein Tyrosine Phosphatase 1B Protects Against Sepsis-Induced Cardiovascular Dysfunction and Mortality

R. Neviere, P. Mulder, V. Richard, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Arteriogenic Therapy by Intramyocardial Sustained Delivery of a Novel Growth Factor Combination Prevents Chronic Heart Failure

F. Lallemand, P. Mulder, V. Richard, 2011, Circulation.

Gene Deletion of Protein Tyrosine Phosphatase 1B Protects Against Sepsis-Induced Cardiovascular Dysfunction and Mortality

R. Neviere, P. Mulder, V. Richard, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure

P. Mulder, V. Richard, J. Martinet, 2016, Circulation. Heart failure.